featured
Adjuvant Pharmacogenomic-Driven Chemotherapy in Completely Resected Stage II–IIIA NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
International Tailored Chemotherapy Adjuvant (ITACA) Trial, a Phase III Multicenter Randomized Trial Comparing Adjuvant Pharmacogenomic-Driven Chemotherapy versus Standard Adjuvant Chemotherapy in completely Resected Stage II-IIIA Non-Small Cell Lung Cancer
Ann. Oncol 2021 Oct 05;[EPub Ahead of Print], S Novello, V Torri, C Grohe, S Kurz, M Serke, T Wehler, A Meyer, D Ladage, M Geissler, I Colantonio, C Cauchi, E Stoelben, A Ceribelli, C Kropf-Sanchen, G Valmadre, G Borra, M Schena, A Morabito, A Santo, V Gregorc, R Chiari, M Reck, G Schmid-Bindert, G Folprecht, F Griesinger, A Follador, P Pedrazzoli, A Bearz, O Caffo, NJ Dickgreber, L Irtelli, G Wiest, V Monica, L Porcu, C Manegold, GV ScagliottiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.